CN102716492A - 黄芩苷羟丙基-β-环糊精包合物及其制备方法与应用 - Google Patents
黄芩苷羟丙基-β-环糊精包合物及其制备方法与应用 Download PDFInfo
- Publication number
- CN102716492A CN102716492A CN2012102405588A CN201210240558A CN102716492A CN 102716492 A CN102716492 A CN 102716492A CN 2012102405588 A CN2012102405588 A CN 2012102405588A CN 201210240558 A CN201210240558 A CN 201210240558A CN 102716492 A CN102716492 A CN 102716492A
- Authority
- CN
- China
- Prior art keywords
- baicalin
- beta
- hydroxypropyl
- cyclodextrin inclusion
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 title claims abstract description 129
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 title claims abstract description 129
- 229960003321 baicalin Drugs 0.000 title claims abstract description 129
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 title claims abstract description 129
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 title claims abstract description 82
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 150000001875 compounds Chemical class 0.000 title abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000012153 distilled water Substances 0.000 claims abstract description 25
- 238000003756 stirring Methods 0.000 claims abstract description 19
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000012670 alkaline solution Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 230000001143 conditioned effect Effects 0.000 claims description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 4
- 239000000920 calcium hydroxide Substances 0.000 claims description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 4
- 239000011736 potassium bicarbonate Substances 0.000 claims description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 235000011181 potassium carbonates Nutrition 0.000 claims description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000292 calcium oxide Substances 0.000 claims description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 230000001741 anti-phlogistic effect Effects 0.000 claims description 2
- 230000036407 pain Effects 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000004108 freeze drying Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- NWKHIZXZESQPSP-UHFFFAOYSA-N acetonitrile;phosphoric acid;hydrate Chemical compound O.CC#N.OP(O)(O)=O NWKHIZXZESQPSP-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- YVECGMZCTULTIS-PBXRRBTRSA-N glucal Chemical compound OC[C@H]1OC=C[C@@H](O)[C@@H]1O YVECGMZCTULTIS-PBXRRBTRSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210240558.8A CN102716492B (zh) | 2012-07-12 | 2012-07-12 | 黄芩苷羟丙基-β-环糊精包合物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210240558.8A CN102716492B (zh) | 2012-07-12 | 2012-07-12 | 黄芩苷羟丙基-β-环糊精包合物及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102716492A true CN102716492A (zh) | 2012-10-10 |
CN102716492B CN102716492B (zh) | 2014-04-23 |
Family
ID=46942444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210240558.8A Expired - Fee Related CN102716492B (zh) | 2012-07-12 | 2012-07-12 | 黄芩苷羟丙基-β-环糊精包合物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102716492B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105617391B (zh) * | 2015-12-31 | 2019-01-18 | 河北医科大学 | 一种黄芩苷结肠靶向药物制剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1552449A (zh) * | 2003-06-06 | 2004-12-08 | 毛友昌 | 黄芩苷环糊精包合物、制剂及制备方法 |
-
2012
- 2012-07-12 CN CN201210240558.8A patent/CN102716492B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1552449A (zh) * | 2003-06-06 | 2004-12-08 | 毛友昌 | 黄芩苷环糊精包合物、制剂及制备方法 |
Non-Patent Citations (2)
Title |
---|
《中成药》 20010531 邵伟等 "黄芩甙-羟丙基-beta-环糊精包合物的研究" 第318-321页 1-10 第23卷, 第5期 * |
邵伟等: ""黄芩甙-羟丙基-β-环糊精包合物的研究"", 《中成药》, vol. 23, no. 5, 31 May 2001 (2001-05-31), pages 318 - 321 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105617391B (zh) * | 2015-12-31 | 2019-01-18 | 河北医科大学 | 一种黄芩苷结肠靶向药物制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102716492B (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103570663B (zh) | 一种高纯度槲皮素的制备方法 | |
CN101721400A (zh) | 阿魏酸在增加某些药物的药效作用及其用途 | |
CN100577677C (zh) | 络石藤总木脂素提取物,提取方法及该提取物和其中有效成分的医药用途 | |
CN101434635B (zh) | 一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法 | |
CN104644711A (zh) | 一种艾纳香属植物提取物及其制备方法与应用 | |
CN102675387B (zh) | 一种从黄芩中提取黄芩苷的方法 | |
CN101781355B (zh) | 柠檬苦素的制备方法及组合物和其应用 | |
CN101156906B (zh) | 一种葛根芩连药物组合物 | |
CN104402963A (zh) | 一种七叶皂苷钠的制备方法 | |
CN105911192B (zh) | 一种半枫荷活血化瘀活性部位的提取方法及指纹图谱检测方法 | |
CN102030804B (zh) | 一种制备茶皂苷元的方法 | |
CN102716492B (zh) | 黄芩苷羟丙基-β-环糊精包合物及其制备方法与应用 | |
CN102875615B (zh) | 大麻药苷a和大麻药总皂苷的提取方法及其应用 | |
CN106265791A (zh) | 一种檀香叶抗炎有效部位及其制备方法和应用 | |
CN105198943A (zh) | 一种名为茶山奈苷a的酰化黄酮糖苷及其制备方法和应用 | |
CN103044377B (zh) | 具有抑制黄嘌呤氧化酶和降尿酸作用的化合物以及组合物 | |
CN104146959A (zh) | 冬凌草甲素缓释脂质体及其制备方法 | |
CN104383547B (zh) | 天山雪莲提取物磷脂复合物、口腔崩解片及其制备方法 | |
CN102178725A (zh) | 黄花草木犀总皂苷及其制备方法和药物用途 | |
CN103099862A (zh) | 治疗风湿痹痛疾病的外用制剂及其制备方法和应用 | |
CN102198209B (zh) | 一种舒筋活血胶囊及其制备工艺 | |
CN102600191B (zh) | 青葙皂苷类化合物在制备抗肿瘤或抗炎药物中的应用 | |
CN102702215B (zh) | 化合物mangostenone F及其制备方法和在制备抗肿瘤药物中的应用 | |
CN103304522B (zh) | 一种具有抑制神经炎症活性的化合物及其制备方法与应用 | |
CN104825634B (zh) | 地黄叶提取物及其在制备治疗急性肾损伤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN KEBAIDE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: GUO DALIANG Effective date: 20150819 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150819 Address after: 300000 Tianjin City, Hexi District Liberation Road and Wu Dao Jiaokou southwest side hailrun Plaza 6-411 Patentee after: Tianjin Ke Paterson Technology Co. Ltd. Address before: 300193 Yuquanlu Road 88 University of traditional Chinese medicine, Nankai District, Tianjin Patentee before: Guo Daliang |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140423 Termination date: 20190712 |
|
CF01 | Termination of patent right due to non-payment of annual fee |